Thomas Weimbs, an Associate Professor in the Molecular, Cellular and Developmental Biology Department since 2007, has a lab at UCSB focuses on uncovering the underlying mechanisms of Autosomal Dominant Polycystic Kidney Disease (ADPKD), a common genetic disease for which a cure still remains elusive. He is a leading expert in biomedical research.

Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease –– although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.

This fellowship will support Jacob's thesis research investigating mechanisms underlying polycystic kidney disease.